The association of the paraoxonase (PON1) Q192R polymorphism with depression in older women: Findings from the British Women's Heart and Health Study

Journal of Epidemiology and Community Health

Volumn 61, Issue 1, 2007, Pages 85-87

  Lawlor, Debbie A ^a   Day, Ian N M ^b   Gaunt, Tom R ^b   Hinks, Lesley J ^b   Timpson, Nick ^a   Ebrahim, Shah ^c   Davey Smith, George ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1;

ALLELE; ELDERLY POPULATION; ENZYME; GENOTYPE-ENVIRONMENT INTERACTION; HEALTH SURVEY; MENTAL HEALTH; MORBIDITY; OCCUPATIONAL EXPOSURE; POLYMORPHISM; POPULATION GENETICS; SYMPTOM; TOXIN; WOMENS HEALTH;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DNA POLYMORPHISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; WOMEN'S HEALTH;

AGED; ARYLDIALKYLPHOSPHATASE; DEPRESSIVE DISORDER; FEMALE; GREAT BRITAIN; HUMANS; LEG; MIDDLE AGED; PAIN; POLYMORPHISM, GENETIC;

EURASIA; EUROPE; UNITED KINGDOM; WESTERN EUROPE;

CINCLIDAE; OVIS ARIES;

EID: 33846284557     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.2006.049247     Document Type: Article

References (12)

1. Cherry N, Mackness M, Durrington P, et al. Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dip. Lancet 2002;359:763-4.
2. Davies HG, Richter RJ, Keifer M, et al. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 1996;14:334-6.
3. Mackness B, Durrington P, Povey A, et al. Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep. Pharmocogenetics 2003;13:81-8.
4. Haley RW, Billecke S, La Du BN. Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicol Appl Pharmacol 1999;157:227-33.
5. Davey Smith G, Ebrahim S. "Mendelian randomisation": can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22.
6. Davey Smith G, Ebrahim S. What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ 2005;330:1070-9.
7. Lawlor DA, Bedford C, Taylor M, et al. Geographic variation in cardiovascular disease, risk factors and their control in older women: British Women's Heart and Health Study. J Epidemiol Community Health 2003;57:134-40.
8. Lawlor DA, Day INM, Gaunt TR, et al. The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health Study and a meta-analysis. BMC Genet 2004;5:17.
9. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
10. Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992;48:361-72.
11. O'Leary KA, Edwards RJ, Town MM, et al. Genetic and other sources of variation in the activity of serum paraoxonase/diazoxonase in humans: consequences for risk from exposure to diazinon. Pharmacogenet Genomics 2005;15:51-60.
12. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003;361:865- 72.